214 related articles for article (PubMed ID: 31865196)
1. Haematological side effects associated with clozapine: A retrospective study from India.
Grover S; Shouan A; Chakrabarti S; Avasthi A
Asian J Psychiatr; 2020 Feb; 48():101906. PubMed ID: 31865196
[TBL] [Abstract][Full Text] [Related]
2. Clozapine-induced blood dyscrasias in Saudi Arab patients.
Abanmy NO; Al-Jaloud A; Al-Jabr A; Al-Ruwaisan R; Al-Saeed W; Fatani S
Int J Clin Pharm; 2014 Aug; 36(4):815-20. PubMed ID: 24917217
[TBL] [Abstract][Full Text] [Related]
3. Clozapine-Induced Eosinophilia: a Case Report.
Monteleone F; Gonçalves M; Fonseca L; Simões S; Gonçalves A; Machado E; Fonseca J
Rev Colomb Psiquiatr (Engl Ed); 2023; 52(2):161-164. PubMed ID: 37500239
[TBL] [Abstract][Full Text] [Related]
4. Clozapine-associated severe eosinophilia following lithium rebound neutropenia: A case report.
Kikuchi K; Yasui-Furukori N; Yokoyama S; Hasegawa C; Kokubun A; Katsukura S; Shimizu T; Shimoda K
Neuropsychopharmacol Rep; 2020 Dec; 40(4):388-391. PubMed ID: 32951324
[TBL] [Abstract][Full Text] [Related]
5. Blood dyscrasias in clozapine-treated patients in Italy.
Lambertenghi Deliliers G
Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
[TBL] [Abstract][Full Text] [Related]
6. Does eosinophilia predict clozapine induced neutropenia?
Hummer M; Sperner-Unterweger B; Kemmler G; Falk M; Kurz M; Oberbauer H; Fleischhacker WW
Psychopharmacology (Berl); 1996 Mar; 124(1-2):201-4. PubMed ID: 8935817
[TBL] [Abstract][Full Text] [Related]
7. Clozapine-induced transient white blood count disorders.
Hummer M; Kurz M; Barnas C; Saria A; Fleischhacker WW
J Clin Psychiatry; 1994 Oct; 55(10):429-32. PubMed ID: 7961519
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Clozapine on Hematological Indices: A 1-Year Follow-Up Study.
Lee J; Takeuchi H; Fervaha G; Powell V; Bhaloo A; Bies R; Remington G
J Clin Psychopharmacol; 2015 Oct; 35(5):510-6. PubMed ID: 26267420
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of eosinophilia for neutropenia during clozapine treatment.
Ames D; Wirshing WC; Baker RW; Umbricht DS; Sun AB; Carter J; Schooler NR; Kane JM; Marder SR
J Clin Psychiatry; 1996 Dec; 57(12):579-81. PubMed ID: 9010121
[TBL] [Abstract][Full Text] [Related]
10. High risk of eosinophilia in women treated with clozapine.
Banov MD; Tohen M; Friedberg J
J Clin Psychiatry; 1993 Dec; 54(12):466-9. PubMed ID: 8276737
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland.
Tiihonen J; Tanskanen A; Bell JS; Dawson JL; Kataja V; Taipale H
Lancet Psychiatry; 2022 May; 9(5):353-362. PubMed ID: 35334224
[TBL] [Abstract][Full Text] [Related]
12. Neutropenia induced by second generation antipsychotics: a prospective investigation.
Rettenbacher MA; Hofer A; Kemmler G; Fleischhacker WW
Pharmacopsychiatry; 2010 Mar; 43(2):41-4. PubMed ID: 20175050
[TBL] [Abstract][Full Text] [Related]
13. Can we prevent blood dyscrasia (leucopenia, thrombocytopenia) and epileptic seizures induced by clozapine.
Herceg M; Muzinić L; Jukić V
Psychiatr Danub; 2010 Mar; 22(1):85-9. PubMed ID: 20305597
[TBL] [Abstract][Full Text] [Related]
14. Hematological adverse events in clozapine-treated children and adolescents.
Gerbino-Rosen G; Roofeh D; Tompkins DA; Feryo D; Nusser L; Kranzler H; Napolitano B; Frederickson A; Henderson I; Rhinewine J; Kumra S
J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
[TBL] [Abstract][Full Text] [Related]
15. Successful challenge with clozapine in a history of eosinophilia.
Schuepbach D; Merlo MC; Kaeser L; Brenner HD
Int Clin Psychopharmacol; 1998 Jan; 13(1):33-7. PubMed ID: 9988365
[TBL] [Abstract][Full Text] [Related]
16. Psychopharmacologic treatment of psychosis in children and adolescents: efficacy and management.
Kranzler HN; Cohen SD
Child Adolesc Psychiatr Clin N Am; 2013 Oct; 22(4):727-44. PubMed ID: 24012083
[TBL] [Abstract][Full Text] [Related]
17. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland.
Atkin K; Kendall F; Gould D; Freeman H; Liberman J; O'Sullivan D
Br J Psychiatry; 1996 Oct; 169(4):483-8. PubMed ID: 8894200
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 infection causes a reduction in neutrophil counts in patients taking clozapine.
Gee S; Taylor D
J Psychiatry Neurosci; 2021 Mar; 46(2):E232-E237. PubMed ID: 33703870
[TBL] [Abstract][Full Text] [Related]
19. Genetic Determinants of Clozapine-Induced Metabolic Side Effects.
Vasudev K; Choi YH; Norman R; Kim RB; Schwarz UI
Can J Psychiatry; 2017 Feb; 62(2):138-149. PubMed ID: 27681143
[TBL] [Abstract][Full Text] [Related]
20. Reason for clozapine cessation.
Pai NB; Vella SC
Acta Psychiatr Scand; 2012 Jan; 125(1):39-44. PubMed ID: 22017729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]